Jun. 2, 2020
This increase has been mostly to thank to the new biological solutions in crop protection and pest control that have followed the launch in 2018 of the nematicide BioAct® Prime and the digital tool Nematool. These, together with the fungicides Serenade ASO® and Sonata® and the insecticide Flipper®, have been the main contributors to that growth.
This year, the company, which has also performed well globally, is strengthening its commitment to sustainability, adhering to the United Nations Sustainable Development Goals (SDGs) and following its Science for a better life purpose. “We are working to respond to some of the world's greatest challenges in the area of health and nutrition. The figures that we are now presenting have helped Bayer consolidate as an important contributor in Spain and confirm our commitment to the country, with a focus on investment and research,” said Bernardo Kanahuati, CEO of Bayer in Spain and Portugal.
Considerable investments in Spain
In 2019, Bayer achieved its highest investment figure in Spain, with more than 60 million Euro (US$ 66 million). Close to 60% of this has been invested in the areas of research and development, in which Spain is a global leader in the area of agriculture, as it hosts an important agronomic development hub in the south of the country.
In terms of investment in infrastructure, the company has also achieved a record figure, doubling its average investment compared to previous years. This is the result of the expansion of some of its production centers, such as that of Berlimed in Alcalá de Henares, and of its agronomic development center in Almería. Overall, there is a clear focus on improving the facilities based on sustainability and efficiency criteria.
More from AgroNews
Subscribe to daily email alerts of AgroNews.